Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.

Published on May 1, 2013in International Journal of Radiation Oncology Biology Physics5.859
· DOI :10.1016/J.IJROBP.2013.01.017
Ann H. Klopp31
Estimated H-index: 31
(University of Texas MD Anderson Cancer Center),
Jennifer Moughan32
Estimated H-index: 32
+ 9 AuthorsAnuja Jhingran42
Estimated H-index: 42
(University of Texas MD Anderson Cancer Center)
Sources
Abstract
Purpose Intensity modulated radiation therapy (IMRT), compared with conventional 4-field treatment, can reduce the volume of bone marrow irradiated. Pelvic bone marrow sparing has produced a clinically significant reduction in hematologic toxicity (HT). This analysis investigated HT in Radiation Therapy Oncology Group (RTOG) 0418, a prospective study to test the feasibility of delivering postoperative IMRT for cervical and endometrial cancer in a multiinstitutional setting. Methods and Materials Patients in the RTOG 0418 study were treated with postoperative IMRT to 50.4 Gy to the pelvic lymphatics and vagina. Endometrial cancer patients received IMRT alone, whereas patients with cervical cancer received IMRT and weekly cisplatin (40 mg/m 2 ). Pelvic bone marrow was defined within the treatment field by using a computed tomography density-based autocontouring algorithm. The volume of bone marrow receiving 10, 20, 30, and 40 Gy and the median dose to bone marrow were correlated with HT, graded by Common Terminology Criteria for Adverse Events, version 3.0, criteria. Results Eighty-three patients were eligible for analysis (43 with endometrial cancer and 40 with cervical cancer). Patients with cervical cancer treated with weekly cisplatin and pelvic IMRT had grades 1-5 HT (23%, 33%, 25%, 0%, and 0% of patients, respectively). Among patients with cervical cancer, 83% received 5 or more cycles of cisplatin, and 90% received at least 4 cycles of cisplatin. The median percentage volume of bone marrow receiving 10, 20, 30, and 40 Gy in all 83 patients, respectively, was 96%, 84%, 61%, and 37%. Among cervical cancer patients with a V40 >37%, 75% had grade 2 or higher HT compared with 40% of patients with a V40 less than or equal to 37% ( P =.025). Cervical cancer patients with a median bone marrow dose of >34.2 Gy also had higher rates of grade ≥2 HT than did those with a dose of ≤34.2 Gy (74% vs 43%, P =.049). Conclusions Pelvic IMRT with weekly cisplatin is associated with low rates of HT and high rates of weekly cisplatin use. The volume of bone marrow receiving 40 Gy and the median dose to bone marrow correlated with higher rates of grade ≥2 toxicity among patients receiving weekly cisplatin (cervical cancer patients). Evaluation and limitation of the volume of bone marrow treated with pelvic IMRT is warranted in patients receiving concurrent chemotherapy.
📖 Papers frequently viewed together
275 Citations
80 Citations
73 Citations
References14
Newest
#1Alfonso Dueñas-González (UNAM: National Autonomous University of Mexico)H-Index: 43
#2J. J. ZarbaH-Index: 10
Last. Mauro OrlandoH-Index: 20
view all 11 authors...
Purpose To determine whether addition of gemcitabine to concurrent cisplatin chemoradiotherapy and as adjuvant chemotherapy with cisplatin improves progression-free survival (PFS) at 3 years compared with current standard of care in locally advanced cervical cancer. Patients and Methods Eligible chemotherapy- and radiotherapy-naive patients with stage IIB to IVA disease and Karnofsky performance score 70 were randomly assigned to arm A (cisplatin 40 mg/m 2 and gemcitabine 125 mg/m 2 weekly for 6...
256 CitationsSource
#1Kevin Albuquerque (Loyola University Medical Center)H-Index: 17
#2David Giangreco (LUC: Loyola University Chicago)H-Index: 1
Last. John C. Roeske (LUC: Loyola University Chicago)H-Index: 37
view all 7 authors...
Purpose To determine factors predictive for hematologic toxicity (HT) associated with concurrent chemoradiation for Stage II through IV cervical cancer. Methods and Materials The medical records of 40 women receiving concurrent chemoradiation for cervical cancer were reviewed. Hematologic toxicity was defined by use of Common Terminology Criteria for Adverse Events (version 3.0). Variables predicting for HT including age, body mass index, transfusions, and bone marrow volumes irradiated were inc...
80 CitationsSource
#1Karen Lim (U of T: University of Toronto)H-Index: 10
#2William Small (NU: Northwestern University)H-Index: 60
Last. Anthony Fyles (U of T: University of Toronto)H-Index: 68
view all 20 authors...
Purpose Accurate target definition is vitally important for definitive treatment of cervix cancer with intensity-modulated radiotherapy (IMRT), yet a definition of clinical target volume (CTV) remains variable within the literature. The aim of this study was to develop a consensus CTV definition in preparation for a Phase 2 clinical trial being planned by the Radiation Therapy Oncology Group. Methods and Materials A guidelines consensus working group meeting was convened in June 2008 for the pur...
250 CitationsSource
#1Ann H. Klopp (University of Texas MD Anderson Cancer Center)H-Index: 31
#2Patricia J. Eifel (University of Texas MD Anderson Cancer Center)H-Index: 71
The introduction of concurrent chemotherapy and radiotherapy for the definitive treatment of cervical cancer constituted a major advance in the management of cervical cancer, resulting in a significant improvement in local control, progression-free survival, and overall survival. Since the publication of the results of seminal trials demonstrating the benefits of platinum-based chemotherapy, investigations of new cytotoxic and targeting agents have continued. The success of these studies has bee...
22 CitationsSource
#1Xu Cao (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 23
#2Xiangwei Wu (Shihezi University)H-Index: 12
Last. Frank J. FrassicaH-Index: 47
view all 14 authors...
Radiation therapy can result in bone injury with the development of fractures and often can lead to delayed and nonunion of bone. There is no prevention or treatment for irradiation-induced bone injury. We irradiated the distal half of the mouse left femur to study the mechanism of irradiation-induced bone injury and found that no mesenchymal stem cells (MSCs) were detected in irradiated distal femora or nonirradiated proximal femora. The MSCs in the circulation doubled at 1 week and increased f...
164 CitationsSource
#1Brent S. Rose (UCSD: University of California, San Diego)H-Index: 19
#2Bulent Aydogan (U of C: University of Chicago)H-Index: 21
Last. Loren K. Mell (UCSD: University of California, San Diego)H-Index: 52
view all 11 authors...
Purpose To test the hypothesis that increased pelvic bone marrow (BM) irradiation is associated with increased hematologic toxicity (HT) in cervical cancer patients undergoing chemoradiotherapy and to develop a normal tissue complication probability (NTCP) model for HT. Methods and Materials We tested associations between hematologic nadirs during chemoradiotherapy and the volume of BM receiving ≥10 and 20 Gy (V 10 and V 20 ) using a previously developed linear regression model. The validation c...
132 CitationsSource
#1Beth M. Beadle (University of Texas MD Anderson Cancer Center)H-Index: 34
#2Anuja Jhingran (University of Texas MD Anderson Cancer Center)H-Index: 42
Last. Patricia J. Eifel (University of Texas MD Anderson Cancer Center)H-Index: 71
view all 6 authors...
Purpose To evaluate the magnitude of cervix regression and motion during external beam chemoradiation for cervical cancer. Methods and Materials Sixteen patients with cervical cancer underwent computed tomography scanning before, weekly during, and after conventional chemoradiation. Cervix volumes were calculated to determine the extent of cervix regression. Changes in the center of mass and perimeter of the cervix between scans were used to determine the magnitude of cervix motion. Maximum cerv...
131 CitationsSource
#1Loren K. Mell (UCSD: University of California, San Diego)H-Index: 52
#2H Tiryaki (UIC: University of Illinois at Chicago)H-Index: 2
Last. Bulent Aydogan (U of C: University of Chicago)H-Index: 21
view all 6 authors...
Purpose: To compare bone marrow-sparing intensity-modulated pelvic radiotherapy (BMS-IMRT) with conventional (four-field box and anteroposterior‐posteroanterior [AP‐PA]) techniques in the treatment of cervical cancer. Methods and Materials: The data from 7 cervical cancer patients treated with concurrent chemotherapy and IMRTwithout BMS were analyzed and compared with data using four-field box and AP‐PA techniques. All plans were normalized to cover the planning target volume with the 99% isodos...
201 CitationsSource
#1Loren K. Mell (UIC: University of Illinois at Chicago)H-Index: 52
#2David A. Schomas (Mayo Clinic)H-Index: 9
Last. Steven J. Chmura (UIC: University of Illinois at Chicago)H-Index: 36
view all 11 authors...
Purpose: To test the hypothesis that the volume of pelvic bone marrow (PBM) receiving 10 and 20 Gy or more (PBM-V{sub 10} and PBM-V{sub 20}) is associated with acute hematologic toxicity (HT) in anal cancer patients treated with concurrent chemoradiotherapy. Methods and Materials: We analyzed 48 consecutive anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiation therapy. The median radiation dose to gross tumor and regional lymph nodes was 50.4 and 45 Gy, resp...
201 CitationsSource
#1Kathryn M. Greven (Wake Forest University)H-Index: 33
#2Kathryn Winter (Radiation Therapy Oncology Group)H-Index: 66
Last. Thomas W. Burke (University of Texas MD Anderson Cancer Center)H-Index: 42
view all 6 authors...
Abstract Purpose. A phase II study was completed by the RTOG to assess the feasibility, safety, toxicity, and patterns of recurrence and survival when chemotherapy was combined with adjuvant radiation for patients with high-risk endometrial cancer. Materials and methods. Pathologic requirements included grade 2 or 3 endometrial adenocarcinoma with either >50% myometrial invasion, cervical stromal invasion, or pelvic-confined extrauterine disease. Radiation included 45 Gy in 25 fractions to the p...
279 CitationsSource
Cited By102
Newest
#1Michalis Mazonakis (UoC: University of Crete)H-Index: 13
Last. John Damilakis (UoC: University of Crete)H-Index: 44
view all 3 authors...
This study was conducted to estimate the lifetime radiation-induced bone and soft tissue sarcoma risks from intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for uterine cervix carcinoma. 13 cervical cancer patients were included. The bone and soft tissue structures were defined on patients' treatment planning computed tomography (CT) scans. Both CT-based IMRT and VMAT plans with 6 MV photons delivering 45 Gy to the target site were designed for each patien...
Source
#1Andrea BresolinH-Index: 1
#2A. FaiellaH-Index: 5
Last. Cesare CozzariniH-Index: 43
view all 24 authors...
Abstract Background and purpose To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Materials and methods Complete data of 415 patients enrolled in a multi institute, prospective trial (#NCT02803086) treated with radical (31%), adjuvant (33%) and salvage (36%) intent at a median dose to pelvic nodes/lymph-nodal area of 53Gy were available. The most severe change...
Source
#1R. Donald Harvey (Emory University)H-Index: 29
Last. Thomas S. Uldrick (Fred Hutchinson Cancer Research Center)H-Index: 30
view all 13 authors...
Purpose: Washout periods and concomitant medication exclusions are common in cancer clinical trial protocols. These exclusion criteria are often applied inconsistently and without evidence to justify their use. The authors sought to determine how washout period and concomitant medication allowances can be broadened to speed trial enrollment and improve the generalizability of trial data to a larger oncology practice population without compromising the safety of trial participants. Experimental D...
1 CitationsSource
Resume La moelle osseuse pelvienne est le siege de pres de 50 % de l’hematopoiese totale. La radiotherapie des aires ganglionnaires pelviennes, et des cancers situes a proximite des structures osseuses du bassin, expose a une toxicite hematologique de l’ordre de 30 a 70 %. Cette toxicite depend de nombreux facteurs, notamment la delivrance ou non d’une chimiotherapie concomitante, ainsi que de son type, des volumes osseux irradies, des doses recues, ou encore de la reserve hematopoietique initia...
Source
#1Visham Bhagaloo (UCT: University of Cape Town)
#2Nazreen Bhim (UCT: University of Cape Town)
Last. Nazia Fakie (UCT: University of Cape Town)H-Index: 1
view all 4 authors...
Background: External beam radiotherapy (EBRT) is essential in the management of locally advanced cervical cancer (LACC). Volumetric modulated arc therapy (VMAT) is thought to achieve higher conformity to the planned target volume (PTV) and better sparing of organs at risk (OAR) when compared to three-dimensional conformal radiotherapy (3D-CRT). This study focused on these principles as it applied to treatment and potential toxicity in the management of LACC. Aim: The aim of this study was to com...
Source
#1Tahir Yusufaly (UCSD: University of California, San Diego)H-Index: 7
#2Austin Miller (Roswell Park Cancer Institute)H-Index: 28
Last. Loren K. Mell (UCSD: University of California, San Diego)H-Index: 52
view all 14 authors...
ABSTRACT Background Sparing active bone marrow (ABM) can reduce acute hematologic toxicity in patients undergoing chemoradiotherapy for cervical cancer, but ABM segmentation based on positron emission tomography/computed tomography (PET/CT) is costly. We sought to develop an atlas-based ABM segmentation methods for implementation in a prospective clinical trial. Methods A multi-atlas was built on a training set of 144 patients and validated in 32 patients from the XXX-XXXXX clinical trial. ABM f...
Source
#1Beatriz E. AmendolaH-Index: 17
#2Naipy PerezH-Index: 5
Last. Marco A. AmendolaH-Index: 30
view all 5 authors...
Spatially fractionated radiation therapy (SFRT) has shown promise in generating high tumor response and local control in the treatment of various palliative and locally advanced bulky tumors. SFRT has not yet been studied systematically in cancer of the cervix. Here we report the first series of patients receiving SFRT for advanced/bulky cervical cancer. Ten patients with far-advanced bulky cervical cancer, stage IIIB-IVA (seven squamous cell and three adeno/adenosquamous carcinomas) received la...
Source
#2Umberto RicardiH-Index: 52
Last. Alan Dal PraH-Index: 15
view all 3 authors...
Source
#2Patrick Silvetti (UNITO: University of Turin)H-Index: 2
Last. Pierfrancesco Franco (UNITO: University of Turin)H-Index: 27
view all 13 authors...
Purpose: to investigate the role of selective avoidance of hematopoietically active BM within the pelvis, as defined with 18FDG-PET, employing a targeted IMRT approach, to reduce acute hematologic toxicity (HT) profile in anal cancer patients undergoing concurrent chemo-radiation. Methods: a one-armed two-stage Simon’s design was selected to test the hypothesis that BM-sparing approach would improve by 20% the rate of G0–G2 (vs. G3–G4) HT, from 42% of RTOG 0529 historical data to 62% (α = 0.05 a...
5 CitationsSource
#1Loren K. Mell (UCSD: University of California, San Diego)H-Index: 52
#2Ronghui Xu (UCSD: University of California, San Diego)H-Index: 27
Last. Cheryl C. Saenz (UCSD: University of California, San Diego)H-Index: 20
view all 14 authors...
BACKGROUND: The use of concurrent doublet chemotherapy with radiation for locoregionally advanced cervical cancer (LACC) is limited by gastrointestinal and hematologic toxicity. By reducing radiation dose to bowel and bone marrow, image-guided intensity modulated radiation therapy (IG-IMRT) may improve chemotherapy tolerance. The goal of this study was to determine whether IG-IMRT could lead to improved tolerance to concurrent cisplatin and gemcitabine for LACC. PATIENTS AND METHODS: We conducte...
Source